204 6 Chapter 6 FIRS 2017 European Respiratory Society, on behalf of the Forum of International Respiratory Societies (FIRS). The global impact of respiratory disease, Second Edition. 2017. www. rsnet.org/images/ publications/The_Global_Impact_of_Respiratory_Disease.pdf (accessed prior to 17 November 2020). Gerardi 1996 Gerardi DA, Lovett L, Benoit-Connors ML, Reardon JZ, ZuWallack RL. Variables related to increased mortality following out-patient pulmonary rehabilitation. European Respiratory Journal 1996;9(3):431-5. [PMID: 8730000] Glasgow 2005 Glasgow RE, Wagner EH, Schaefer J, Mahoney LD, Reid RJ, Greene SM. Development and validation of the Patient Assessment of Chronic Illness Care (PACIC). Medical Care 2005;43(5):436-44. [PMID: 15838407 ] GOLD 2009 GOLD 2009. Global initiative for chronic obstructive pulmonary disease. Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, 2009. goldcopd.org/gold-reports/ (accessed 4 October 2013). GOLD 2020 GOLD 2020. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2020 report). goldcopd.org/wp- content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV. pdf (accessed 5 May 2020). Gonseth 2004 Gonseth J, Guallar-Castillon P, Banegas JR, Rodriguez-Artalejo F. The e ectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. European Heart Journal 2004;25(18):1570-95. [PMID: 15351157 ] GRADE Working Group 2004 GRADE Working Group 2004. Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490- 4. Guarascio 2013 Guarascio AJ, Ray SM, Finch CK, Self TH. The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoeconomic and Outcomes Research 2013;5:235-45. Guyatt 1987 Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42(10):773-8. [PMID: 3321537 ] Guyatt 2011 Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15.
RkJQdWJsaXNoZXIy MTk4NDMw